Practice Areas - Equity Capital Markets Law Firms and Lawyers
| Deal Date: | 21-10-2014 | Practice Area: | Equity Capital Markets |
| Deal Title: | Atara Biotherapeutics, Inc NASDAQ Initial Public Offering | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Davis Polk advised Goldman, Sachs and Co. and Citigroup as joint book-running managers in connection with the USD55 million initial public offering of common stock by Atara Biotherapeutics, Inc. Atara Biotherapeutics' common stock is listed on the NASDAQ Global Select Market under the symbol ATRA.
The Davis Polk corporate team included partner Bruce K. Dallas and associates Aaron Justin Epstein and Jeffrey Hedrick. The tax team included partner Rachel D. Kleinberg and associate Patrick E. Sigmon. The intellectual property team included associates Jansen A. S. Thurmer and Nikita A. Tuckett. Counsel Cynthia Akard and Marcie A. Goldstein provided executive compensation and FINRA advice, respectively. Members of the Davis Polk team are based in the Menlo Park, New York and Washington DC offices.
|
||
| Financial Center: | Silicon Valley | Value: | 0.00-100.00 |
| Advised Party: | Lead Managers | Law Firm | Davis Polk |
| Issuer Jurisdiction- | United States | Listing Jurisdiction- | United States |
| Classification: |
Initial Public Offerings NASDAQ |
Lawyer | Bruce K Dallas |
